CE-Ventures, the venture capital arm of UAE-based Crescent Enterprises, and TMC Venture Fund have co-led a $10 million funding round for CrossBridge Bio, a Houston-based biotech firm, with participation from Portal Innovations, Alexandria Ventures, and Linden Lake Labs.
More to Know:
- CrossBridge Bio was founded in 2023 by Michael Jason Torres.
- The startup focuses on developing therapeutics, particularly for solid tumours.